Pallas Capital Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-5,867
Closed -$335K – 279
2023
Q1
$335K Sell
5,867
-45,636
-89% -$2.43M 0.03% 213
2022
Q4
$2.81M Buy
51,503
+38,676
+302% +$1.96M 0.28% 80
2022
Q3
$619K Buy
+12,827
New +$666K 0.07% 156
2022
Q1
– Sell
-9,535
Closed -$564K – 261
2021
Q4
$564K Sell
9,535
-385
-4% -$24.6K 0.07% 184
2021
Q3
$653K Buy
+9,920
New +$633K 0.07% 197

Other funds holding IHI

Pallas Capital Advisors's IHI Position: Q2 2023 in Review

Pallas Capital Advisors sold out of iShares US Medical Devices ETF (IHI) in Q2 2023, closing a stake of 5,867 shares — an estimated $335K sold.

Pallas Capital Advisors first reported a position in IHI in Q3 2021 and held it in 5 quarters. The position peaked at $2.81M in Q4 2022. 586 funds tracked by Wall St. Rank hold IHI as of Q2 2023.

  • Pallas Capital Advisors reported no remaining iShares US Medical Devices ETF position as of Q2 2023 after selling out during the quarter.
  • Pallas Capital Advisors sold 5,867 iShares US Medical Devices ETF shares in Q2 2023, an estimated $335K.
  • Pallas Capital Advisors first reported a position in iShares US Medical Devices ETF in Q3 2021 and held it in 5 quarters.
  • Pallas Capital Advisors's iShares US Medical Devices ETF position peaked at $2.81M in Q4 2022.
  • 586 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2023.

Based on Pallas Capital Advisors's 13F filing for Q2 2023, filed 26 Jul 2023.